Seguir
ROBERT KARGBO
ROBERT KARGBO
Usona Institute
Dirección de correo verificada de usonainstitute.org
Título
Citado por
Citado por
Año
Recent advances in asymmetric hydrogenation of tetrasubstituted olefins
S Kraft, K Ryan, RB Kargbo
Journal of the American Chemical Society 139 (34), 11630-11641, 2017
1492017
Readily accessible, modular, and tuneable BINOL 3, 3 ‘-perfluoroalkylsulfones: Highly efficient catalysts for enantioselective In-mediated imine allylation
R Kargbo, Y Takahashi, S Bhor, GR Cook, GC Lloyd-Jones, ...
Journal of the American Chemical Society 129 (13), 3846-3847, 2007
1122007
Highly diastereoselective indium-mediated allylation of chiral hydrazones
GR Cook, BC Maity, R Kargbo
Organic Letters 6 (11), 1741-1743, 2004
822004
Stereoselective indium-mediated allylation reactions
RB Kargbo, GR Cook
Current Organic Chemistry 11 (15), 1287-1309, 2007
802007
Catalytic enantioselective indium-mediated allylation of hydrazones
GR Cook, R Kargbo, B Maity
Organic Letters 7 (13), 2767-2770, 2005
762005
Synthesis and biological evaluation of tryptamines found in hallucinogenic mushrooms: norbaeocystin, baeocystin, norpsilocin, and aeruginascin
AM Sherwood, AL Halberstadt, AK Klein, JD McCorvy, KW Kaylo, ...
Journal of natural products 83 (2), 461-467, 2020
732020
PROTAC compounds targeting α-synuclein protein for treating neurogenerative disorders: Alzheimer’s and Parkinson’s diseases
RB Kargbo
ACS Medicinal Chemistry Letters 11 (6), 1086-1087, 2020
622020
Treatment of Alzheimer’s by PROTAC-Tau protein degradation
RB Kargbo
ACS Medicinal Chemistry Letters 10 (5), 699-700, 2019
592019
Direct phosphorylation of psilocin enables optimized cGMP kilogram-scale manufacture of psilocybin
RB Kargbo, A Sherwood, A Walker, NV Cozzi, RE Dagger, J Sable, ...
ACS omega 5 (27), 16959-16966, 2020
362020
Asymmetric synthesis of aminochromanes via intramolecular indium-mediated allylation of chiral hydrazones
D Samanta, RB Kargbo, GR Cook
The Journal of organic chemistry 74 (18), 7183-7186, 2009
352009
Psilocybin therapeutic research: the present and future paradigm
RB Kargbo
ACS medicinal chemistry letters 11 (4), 399-402, 2020
332020
Neuroactive steroids, compositions, and uses thereof
GM BOTELLA, BL Harrison, AJ Robichaud, FG Salituro, RJ Herr, ...
US Patent App. 14/913,920, 2016
322016
Scalable hybrid synthetic/biocatalytic route to psilocybin
J Fricke, R Kargbo, L Regestein, C Lenz, G Peschel, MA Rosenbaum, ...
Chemistry–A European Journal 26 (37), 8281-8285, 2020
302020
PROTAC-mediated degradation of estrogen receptor in the treatment of cancer
RB Kargbo
ACS Medicinal Chemistry Letters 10 (10), 1367-1369, 2019
282019
Efficient one-pot synthesis of 2-substituted benzimidazoles from triacyloxyborane intermediates
W Cui, RB Kargbo, Z Sajjadi-Hashemi, F Ahmed, JF Gauuan
Synlett 2012 (02), 247-250, 2012
272012
Taking Different Roads: l‐Tryptophan as the Origin of Psilocybe Natural Products
C Lenz, A Sherwood, R Kargbo, D Hoffmeister
ChemPlusChem 86 (1), 28-35, 2021
262021
Enzymatic route toward 6‐methylated baeocystin and psilocybin
J Fricke, A Sherwood, R Kargbo, A Orry, F Blei, A Naschberger, B Rupp, ...
ChemBioChem 20 (22), 2824-2829, 2019
232019
An improved, practical, and scalable five-step synthesis of psilocybin
AM Sherwood, P Meisenheimer, G Tarpley, RB Kargbo
Synthesis 52 (05), 688-694, 2020
202020
PROTAC-mediated degradation of KRAS protein for anticancer therapeutics
RB Kargbo
ACS Medicinal Chemistry Letters 11 (1), 5-6, 2019
202019
Treatment of Cancer and Alzheimer’s Disease by PROTAC Degradation of EGFR
RB Kargbo
ACS Medicinal Chemistry Letters 10 (8), 1098-1099, 2019
202019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20